Drugmaker Merck said the pill cut hospitalisations and deaths by half among patients with early COVID-19 symptoms

Video. UK approves use of anti-COVID pill molnupiravir

Molnupiravir will be offered to at-risk patients who already have the coronavirus. It is not a substitute for the COVID-19 vaccine, UK authorities said.